Therapeutic indication: GlucaGen is indicated for treatment of severe hypoglycaemic reactions, which may occur in the management of insulin-treated children and adults with diabetes mellitus.
Diagnostic indication: GlucaGen is indicated for motility inhibition in examinations of the gastrointestinal tract in adults.